Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.
Type:
Application
Filed:
August 21, 2002
Publication date:
June 19, 2003
Applicant:
The Regents of the University of Cailifornia
Inventors:
Robert E. Reiter, Owen N. Witte, Douglas C. Saffran, Aya Jakobovits